©The Author(s) 2024.
World J Clin Cases. Mar 26, 2024; 12(9): 1585-1596
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1585
Published online Mar 26, 2024. doi: 10.12998/wjcc.v12.i9.1585
Table 1 Patient characteristics
| Frequency | % | ||
| Age, yr | 1 | 1 | 25.0 |
| 4 | 1 | 25.0 | |
| 9 | 2 | 50.0 | |
| Sex | Female | 1 | 25.0 |
| Male | 3 | 75.0 | |
| Etiology of cerebral palsy | Hypoxia during birth | 2 | 50.0 |
| Hypoxia with bleeding in the surgical field after tonsillectomy operation | 1 | 25.0 | |
| Cardiac arrest | 1 | 25.0 | |
| Comorbidity | None | 4 | 100.0 |
| Cerebral palsy duration and first transplantation | 1 year | 1 | 25.0 |
| 13 months | 1 | 25.0 | |
| 7 years | 1 | 25.0 | |
| 9 years | 1 | 25.0 | |
- Citation: Boyalı O, Kabatas S, Civelek E, Ozdemir O, Bahar-Ozdemir Y, Kaplan N, Savrunlu EC, Karaöz E. Allogeneic mesenchymal stem cells may be a viable treatment modality in cerebral palsy. World J Clin Cases 2024; 12(9): 1585-1596
- URL: https://www.wjgnet.com/2307-8960/full/v12/i9/1585.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v12.i9.1585